Sign up for free insights newsletter
RB

Reckitt Benckiser Group PLC

RBGPFUnited States

Need professional-grade analysis? Visit stockanalysis.com

$67.41
-2.30%
End of day
Market Cap

$44.55B

P/E Ratio

N/A

Employees

N/A

Dividend Yield

431.00%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.91-1.68-1.76
Calmar-13.43-3.90-7.07
Sharpe-2.41-1.66-1.91
Omega0.000.180.12
Martin-22.00-6.60-11.74
Ulcer4.4614.2310.97

Reckitt Benckiser Group PLC (RBGPF) Price Performance

Reckitt Benckiser Group PLC (RBGPF) trades on United States in USD. The company is classified in the Consumer Defensive sector under the Household & Personal Products industry. The stock currently trades at $67.41, down 2.30% from the previous close.

Over the past year, RBGPF has traded between a low of $55.70 and a high of $90.70. The stock has gained 11.7% over this period. It is currently 25.7% below its 52-week high.

Reckitt Benckiser Group PLC has a market capitalization of $44.55B and a dividend yield of 431.00%.

About Reckitt Benckiser Group PLC

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under Airborne, Movefree, and neuriva names; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$14.20B
EBITDA
$3.85B
Profit Margin
22.40%
EPS (TTM)
6.49
Book Value
14.69

Technical Indicators

52 Week High
$90.71
52 Week Low
$55.70
50 Day MA
$82.54
200 Day MA
N/A
Beta
0.10

Valuation

Trailing P/E
10.63
Forward P/E
16.12
Price/Sales
3.14
Price/Book
4.70
Enterprise Value
$53.92B